Impact of the COVID-19 pandemic on clinical trials with drugs

被引：6
作者：
Hasford, Joerg [1 ,2 ]
机构：
[1] Ludwigs Maximilians Univ Muenchen, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany
[2] Assoc Med Eth Comm Germany, Berlin, Germany
来源：
EXPERT OPINION ON DRUG SAFETY | 2020年 / 19卷 / 11期
关键词：
covid-19; clinical trials regulation; clinical trials; patient involvement; pandemic;
D O I：
10.1080/14740338.2020.1828861
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1373 / 1375
页数：3
相关论文
共 7 条
  • [1] Central statistical monitoring of investigator-led clinical trials in oncology
    Buyse, Marc
    Trotta, Laura
    Saad, Everardo D.
    Sakamoto, Junichi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (07) : 1207 - 1214
  • [2] Waste in COVID-19 clinical trials conducted in western Europe
    Dal-Re, Rafael
    Mahillo-Fernandez, Ignacio
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 81 : 91 - 93
  • [3] Herper M, DATA SHOW PANIC DISO
  • [4] Redundant trials can be prevented, if the EU clinical trial regulation is applied duly
    Kim, Daria
    Hasford, Joerg
    [J]. BMC MEDICAL ETHICS, 2020, 21 (01)
  • [5] CORONAVIRUS SHUTS DOWN TRIALS OF DRUGS FOR MULTIPLE OTHER DISEASES
    Ledford, Heidi
    [J]. NATURE, 2020, 580 (7801) : 15 - 16
  • [6] Against pandemic research exceptionalism
    London, Alex John
    Kimmelman, Jonathan
    [J]. SCIENCE, 2020, 368 (6490) : 476 - 477
  • [7] Impact of COVID-19 on oncology clinical trials
    Upadhaya, Samik
    Yu, Jia Xin
    Oliva, Cristina
    Hooton, Megan
    Hodge, Jeffrey
    Hubbard-Lucey, Vanessa M.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (06) : 376 - 377
1